Winter-curly meth is expected to be used in M2 leukemia treatment
-
Last Update: 2020-07-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
, on the 20th anniversary of the establishment of the Research Institute of Hematology of RuijinHospital
, affiliated with Shanghai Jiaotong University School of Medicine, the researchers of the Institute revealed that they have made encouraging progress in the study of M2 leukemia induced differentiation treatmentAccording to the introduction, the institute applied trans-dimensional A acid and arsenic trioxide to coordinate the treatment of acute early childhood leukemia, so that the patient's 5 years disease-free survival rate of more than 90% on the basis of the leukemia induced differentiation treatment to the second type of leukemia (M2 leukemia) - acute granulocytic leukemia partial differentiationThe researchers have found that the Chinese medicine extract, dongling meth, may have achieved good results for M2 leukemia through targeted treatment, and has made important progress in basic theory and animal trialsAt present, the Institute in cooperation with the relevant units, will be launched in the winter oxaformin treatment m2 leukemia clinical trials(Reporter Li Nan resident reporter Wang Min)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
